Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neoadjuvant Hiltonol® (PolyICLC) for Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03262103
Recruitment Status : Recruiting
First Posted : August 25, 2017
Last Update Posted : November 2, 2018
Sponsor:
Collaborator:
Oncovir, Inc.
Information provided by (Responsible Party):
Ashutosh Kumar Tewari, Icahn School of Medicine at Mount Sinai

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 1, 2020
Estimated Study Completion Date : May 1, 2020
Publications: